Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

Affiliations

• ¹ HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town 7505, South Africa; University of Pretoria, Pretoria, South Africa. Electronic address: ameena.goga@mrc.ac.za.
• ² Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
• ³ Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; School of Nursing and Public Health, Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa.
• ⁴ Biostatistics Research Unit, South African Medical Research Council, Cape Town 7505, South Africa.
• ⁵ Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
• ⁶ Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; King's Global Health Institute, King's College London, London, UK.
• ⁷ School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
• ⁸ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ⁹ Right to Care, Johannesburg, South Africa.
• ¹⁰ Office of the President and CEO, South African Medical Research Council, Cape Town 7505, South Africa.